ea0015p270 | Pituitary | SFEBES2008
Mitnala Sirisha
, Elmalti Akrem
, Dawson Alison
, Belchetz Paul
, Orme Steve
, Swinburne Julie
, Walton Sue
, Murray Robert D
Patients with GHD have an, adverse body composition, insulin resistance, atherogenic lipid profile and impaired quality of life. We undertook a single centre retrospective audit of hypopituitary adults to quantify the long-term effects of dose-titrated GH replacement.The cohort comprised 53 patients defined as severely GHD using the GST (median peak GH 2.4 μ/l). Mean age 42±16.9 years, 23F, BMI 29.3±5.3 kg/m2. GH was titrated un...